Nau'ikan Maganin Jiyya na Kansa don Maganin Ciwon daji
Immunotherapy wata hanya ce ta magance ciwon daji wadda ke amfani da tsarin garkuwar jiki don gane da kuma yaƙar ƙwayoyin cutar kansa. Ba kamar chemotherapy ba, wanda ke kai hari ga ƙwayoyin cuta da sauri, ko radiotherapy, wanda ke lalata DNA na ƙwayoyin cuta ta hanyar radiation, immunotherapy yana aiki ta hanyar "ƙara," "jagoranci," ko "sakin birki" akan amsawar garkuwar jiki, yana sa jiki ya fi tasiri wajen lalata ciwon daji. A cikin 'yan shekarun nan, immunotherapy ya zama babban ci gaba a fannin oncology saboda yana iya samar da amsoshi masu ɗorewa ga wasu marasa lafiya, har ma a cikin ciwon daji waɗanda a da suke da wahalar magani.
Duk da haka, maganin rigakafi bai dace da dukkan nau'ikan ciwon daji ko duk marasa lafiya ba. Illolin da za su iya faruwa na iya bambanta da na gargajiya, galibi suna da alaƙa da yawan kunna tsarin garkuwar jiki. Saboda haka, zaɓin maganin rigakafi yawanci ya dogara ne akan nau'in ciwon daji, matakin cutar, yanayin majiyyaci, da takamaiman alamun cutar. Ga waɗannan nau'ikan maganin rigakafi da aka fi amfani da su wajen maganin ciwon daji.
1. Masu Hana Duban Gawarwaki (Masu Hana Duban Gawarwaki)
Ɗaya daga cikin shahararrun nau'ikan maganin rigakafi shine hana garkuwar jiki. Tsarin garkuwar jiki yana da "wuraren duba lafiya," hanyoyin halitta waɗanda ke hana martanin garkuwar jiki da yawa waɗanda zasu iya lalata kyallen jikin mutum. Kwayoyin cutar kansa galibi suna amfani da waɗannan wuraren binciken don "ɓoye" daga harin ƙwayoyin T (ƙwayoyin garkuwar jiki masu kisa).
Masu hana binciken ababen hawa suna aiki ta hanyar toshe takamaiman sunadaran wuraren duba ababen hawa, suna ba ƙwayoyin T damar sake kunnawa da kuma kai hari ga ƙwayoyin cutar kansa. Manyan abubuwan da aka fi so guda biyu sune:
– PD-1/PD-L1 (An Shirya Mutuwa-1 / Ligand-1): Kwayoyin cutar kansa na iya bayyana PD-L1 don "kashe" ƙwayoyin T. Magungunan da ke hana PD-1 ko PD-L1 na iya taimakawa wajen sake buɗe ayyukan ƙwayoyin T.
– CTLA-4 (T-Lymphocyte-Associated Protein 4): CTLA-4 yana taka rawa wajen kunna ƙwayoyin T, musamman a farkon matakan amsawar garkuwar jiki.
Ana amfani da magungunan hana duba marasa lafiya don magance nau'ikan cututtukan daji daban-daban, ciki har da melanoma, ciwon huhu, ciwon koda, ciwon mafitsara, da kuma wasu cututtukan daji na kai da wuya. Fa'idar wannan maganin ita ce yuwuwar samun sakamako mai ɗorewa, amma haɗari sun haɗa da illolin da ke tattare da garkuwar jiki kamar su colitis, ciwon huhu, matsalolin thyroid, har ma da cutar hepatitis ta jiki.
2. Maganin Kwayoyin T na CAR (Maganin Kwayoyin T na CAR)
Maganin ƙwayoyin T na CAR wani maganin rigakafi ne na musamman. A cikin wannan maganin, ana ɗaukar ƙwayoyin T na majiyyaci daga jini sannan a gyara su a dakin gwaje-gwaje don samun mai karɓa na musamman da ake kira Chimeric Antigen Receptor (CAR). An tsara wannan mai karɓa don gane takamaiman antigens a saman ƙwayoyin cutar kansa. Da zarar an gyara su kuma an ninka su, ana mayar da ƙwayoyin T zuwa jikin majiyyaci don neman da lalata ƙwayoyin cutar kansa da aka yi niyya.
Maganin ƙwayoyin T na CAR ya nuna babban nasara musamman a wasu cututtukan daji na jini, kamar:
- cutar sankarar lymphoblastic mai tsanani (DUK) a wasu lokuta,
- wasu nau'ikan lymphomas marasa Hodgkin,
- myeloma mai yawa a cikin wasu alamomi.
Duk da haka, wannan maganin yana iya haifar da mummunan sakamako, kamar Cytokine Release Syndrome (CRS), wanda ke haifar da zazzabi mai yawa da ƙarancin hawan jini, da kuma wasu matsalolin jijiyoyi. Bugu da ƙari, farashi da wadatar kayan aiki ƙalubale ne saboda tsari mai rikitarwa.
3. Kwayoyin rigakafi na Monoclonal
Kwayoyin rigakafi na monoclonal sunadarai ne na roba waɗanda aka tsara don haɗawa da takamaiman abubuwan da ke kan ƙwayoyin cutar kansa. Ta hanyar "yi wa" ƙwayoyin cutar kansa alama, ƙwayoyin rigakafi suna taimaka wa tsarin garkuwar jiki ya gane ciwace-ciwacen ko kuma ya wargaza alamun ci gaban cutar kansa.
Akwai hanyoyi da dama na monoclonal antibodies suna aiki a cikin ciwon daji:
1. Magungunan rigakafi masu niyya ga masu karɓa: suna hana siginar girma a cikin ƙwayoyin cutar kansa.
2. Kwayoyin rigakafi da ke haifar da lalacewa ta hanyar tsarin garkuwar jiki: suna jawo hankalin ƙwayoyin garkuwar jiki don kai hari ga ƙwayoyin da aka yiwa alama.
3. Magungunan rigakafi da haɗin magunguna (ADC): ƙwayoyin rigakafi suna ɗaukar “nauyin” magungunan chemotherapy zuwa ƙwayoyin cutar kansa don a fi mayar da hankali a kansu.
4. Maganin Radioimmunotherapy: ƙwayoyin rigakafi suna ɗaukar abubuwa masu rediyoaktif zuwa ƙari.
Ana amfani da ƙwayoyin rigakafi na monoclonal sosai don magance nau'ikan ciwon daji daban-daban, ciki har da ciwon nono , lymphoma, ciwon daji na hanji, da sauransu. Illolin da ke tattare da hakan sun bambanta, tun daga amsawar jiko da kurajen fata zuwa lalacewar gabobi, ya danganta da abin da aka nufa.
4. Allurar Rigakafin Ciwon Daji
Allurar rigakafi ta ciwon daji tana da nufin sa tsarin garkuwar jiki ya gane kwayoyin cutar kansa. Ba kamar alluran rigakafi don hana cututtuka masu yaduwa ba , alluran rigakafin ciwon daji sun kasu kashi biyu:
– Allurar rigakafi: hana cutar kansa da wasu ƙwayoyin cuta ke haifarwa. Misali mafi shahara shine allurar rigakafin HPV, wanda ke rage haɗarin. ciwon daji na mahaifa da kuma wasu cututtukan daji na kai da wuya, da kuma allurar rigakafin cutar hepatitis B don rage haɗarin kamuwa da cutar kansar hanta.
– Allurar rigakafi: ana ba wa marasa lafiya da suka riga suka kamu da cutar kansa don taimakawa garkuwar jiki ta kai hari ga ciwon.
Allurar rigakafi ta hanyar magani yawanci tana kai hari ga ƙwayoyin cuta na musamman ga ciwon majiyyaci ko kuma ƙwayoyin cuta da suka zama ruwan dare gama gari ga wasu nau'ikan ciwon daji. Amsoshin na iya bambanta, kuma bincike yana ci gaba da inganta inganci, gami da amfani da haɗin magungunan hana bincike.
5. Maganin Cytokine
Cytokines suna nuna ƙwayoyin halitta waɗanda ƙwayoyin rigakafi ke amfani da su don sadarwa da daidaita martanin garkuwar jiki. A cikin maganin ciwon daji, ana iya ba da wasu cytokines don haɓaka aikin garkuwar jiki.
Misalan cytokines da aka yi amfani da su sosai sun haɗa da:
– Interleukin-2 (IL-2): na iya ƙarfafa yaɗuwar ƙwayoyin T da ƙwayoyin NK (masu kashe ƙwayoyin halitta). An yi amfani da shi a wasu cututtukan daji na koda da melanoma.
- Interferon alpha: yana iya haɓaka amsawar garkuwar jiki kuma yana da tasirin hana yaɗuwa akan wasu cututtukan daji.
Maganin Cytokine na iya yin tasiri ga wasu marasa lafiya, amma sau da yawa yana da illa kamar zazzabi, gajiya mai tsanani, ƙarancin hawan jini, da kuma rashin aikin gabobin jiki, don haka amfani da shi yanzu ya fi zaɓi kuma sau da yawa ana maye gurbinsa da takamaiman magungunan rigakafi.
6. Maganin Cutar Kanjamau
Maganin cutar Oncolytic yana amfani da ƙwayoyin cuta da aka gyara don kamuwa da ƙwayoyin cutar kansa da kuma lalata su, yayin da a lokaci guda kuma yana "farka" tsarin garkuwar jiki don gane ciwon. Lokacin da kwayar cutar ta lalata ƙwayoyin cutar kansa (ta lalata su), ana fitar da ƙwayoyin cutar kansa, wanda ke haifar da martani mai faɗi ga garkuwar jiki.
Wannan maganin yana da kyau domin yana aiki ta hanyoyi guda biyu: lalata ƙwayoyin ƙari kai tsaye da kunna tsarin garkuwar jiki na hana ciwon daji. Galibi ana ba shi ta hanyar allura kai tsaye a cikin ciwon. Ana ci gaba da bincike don faɗaɗa amfani da shi a cikin nau'ikan ciwon daji daban-daban da kuma haɗa shi da masu hana binciken wuri don samun ƙarin ƙarfi.
7. Maganin TIL da Sauran Maganin Garkuwar Kwayoyin Halitta
Bayan CAR T, akwai wasu hanyoyin da ake kira maganin ƙwayoyin haihuwa, kamar maganin lymphocytes masu shiga cikin ƙwayoyin cuta (TIL). A cikin maganin TIL, likitoci suna ɗaukar ƙwayoyin rigakafi da ke cikin ƙwayoyin cuta (lymphocytes waɗanda ke "shiga" ƙwayar cuta), suna ninka su a cikin dakin gwaje-gwaje, sannan su mayar da su ga majiyyaci. Saboda waɗannan ƙwayoyin an "horar da su" don gane yanayin ciwon, wannan maganin zai iya yin tasiri a wasu lokuta, musamman a cikin mahallin bincike da wasu cibiyoyin ciwon daji.
Akwai kuma hanyoyin da ake bi wajen ƙirƙirar ƙwayoyin T tare da wasu masu karɓa (misali, ƙwayoyin T da aka ƙera ta hanyar TCR), waɗanda ke kai hari ga ƙwayoyin cutar kansa ta hanyar wata hanyar gane su daban fiye da CARs.
Haɗakar Immunotherapy da Kalubalen Nan Gaba
A aikin asibiti , galibi ana haɗa maganin rigakafi da chemotherapy, radiotherapy, magani mai niyya, ko haɗin magungunan rigakafi. Manufar ita ce ƙara damar amsawa, shawo kan juriya, da faɗaɗa adadin marasa lafiya da za su iya amfana.
Duk da haka, akwai manyan ƙalubale, kamar:
- ba duk marasa lafiya ke amsawa ba,
- hasashen amsawa yana buƙatar takamaiman alamun halitta (misali bayyanar PD-L1, nauyin maye gurbin ƙari, MSI-mai yawa a cikin wasu cututtukan daji),
- ya kamata a kula da illolin da ke tattare da cututtukan autoimmune sosai,
- samun dama da kuma kuɗin magani ya kasance matsala a wurare da yawa.
Penutup
Maganin rigakafi ya canza yanayin maganin ciwon daji ta hanyar bayar da sabuwar hanya don amfani da ƙarfin tsarin garkuwar jiki . Waɗannan hanyoyin sun haɗa da masu hana wuraren bincike, maganin ƙwayoyin cuta na CAR T, ƙwayoyin rigakafi na monoclonal, alluran rigakafin ciwon daji, maganin cytokine, ƙwayoyin cuta na oncolytic, da magungunan ƙwayoyin haihuwa kamar TILs. Kowace hanya tana da fa'idodi, iyakoki, da alamu daban-daban. Saboda haka, ya kamata a yanke shawara game da maganin rigakafi ta hanyar tuntuɓar likitan kansa, la'akari da nau'in ciwon daji, yanayin majiyyaci, da alamomin da suka dace. Tare da ci gaba da bincike, ana sa ran maganin rigakafi zai zama mafi inganci, aminci, kuma mafi sauƙin samu ga masu fama da ciwon daji.
